Objective: To compare the effects of oral misoprostol 800 ìg with intramuscular oxytocin 10 IU in routine management of the third stage of labour. Methods: This randomized controlled trial was performed in a rural district hospital in Ghana, West Africa, and enrolled women in labour with anticipated vaginal delivery and no known medical contraindication to prostaglandin administration. Women were randomized to receive oral misoprostol 800 ìg or intramuscular oxytocin 10 IU. Blood samples were taken to determine hemoglobin concentration before delivery and at 12 hours post partum. Treatment was administered at delivery of the anterior shoulder. The primary outcome was the change in hemoglobin concentration from before to after delivery. Seco...
International audienceOBJECTIVE: To evaluate the effectiveness and safety of misoprostol administere...
Background: To compare the efficacy of oxytocin, methylergometrine and misoprostol in active managem...
Objective: To compare the safety, efficacy and cost effectiveness of vaginal misoprostol and intrav...
Objective: To compare the effect of rectal misoprostol with intramuscular oxytocin in the routine ma...
Aims: This study aimed at comparing the efficacy of oral misoprostol 600 mcg with intramuscular oxyt...
Aims: This study was done to assess the efficacy of oral misoprostol in the active management of the...
The aim of this study was to compare the efficacy, safety and cost-effectiveness of rectal misoprost...
Objective: To compare low dose sublingual misoprostol with the standard 10 IU of intramuscular oxyto...
BACKGROUND: Postpartum haemorrhage is a leading cause of maternal morbidity and mortality. Active ma...
OBJECTIVE: To investigate whether orally administered misoprostol during the third stage of labor is...
Background: To compare oral misoprostol with intravenous oxytocin for labour augmentation in nullipa...
A double-blind randomised trial was conducted on women with gestational age of 40�42 weeks of preg...
Postpartum hemorrhage (PPH) is a leading cause of maternal death in sub-Saharan Africa. Although the...
Objective: To test the null hypothesis that misoprostol, an oral prostaglandin El analog, is not wor...
Background: The aim of the present study was to compare the effectiveness of sublingual misoprostol,...
International audienceOBJECTIVE: To evaluate the effectiveness and safety of misoprostol administere...
Background: To compare the efficacy of oxytocin, methylergometrine and misoprostol in active managem...
Objective: To compare the safety, efficacy and cost effectiveness of vaginal misoprostol and intrav...
Objective: To compare the effect of rectal misoprostol with intramuscular oxytocin in the routine ma...
Aims: This study aimed at comparing the efficacy of oral misoprostol 600 mcg with intramuscular oxyt...
Aims: This study was done to assess the efficacy of oral misoprostol in the active management of the...
The aim of this study was to compare the efficacy, safety and cost-effectiveness of rectal misoprost...
Objective: To compare low dose sublingual misoprostol with the standard 10 IU of intramuscular oxyto...
BACKGROUND: Postpartum haemorrhage is a leading cause of maternal morbidity and mortality. Active ma...
OBJECTIVE: To investigate whether orally administered misoprostol during the third stage of labor is...
Background: To compare oral misoprostol with intravenous oxytocin for labour augmentation in nullipa...
A double-blind randomised trial was conducted on women with gestational age of 40�42 weeks of preg...
Postpartum hemorrhage (PPH) is a leading cause of maternal death in sub-Saharan Africa. Although the...
Objective: To test the null hypothesis that misoprostol, an oral prostaglandin El analog, is not wor...
Background: The aim of the present study was to compare the effectiveness of sublingual misoprostol,...
International audienceOBJECTIVE: To evaluate the effectiveness and safety of misoprostol administere...
Background: To compare the efficacy of oxytocin, methylergometrine and misoprostol in active managem...
Objective: To compare the safety, efficacy and cost effectiveness of vaginal misoprostol and intrav...